Latest Drug-eluting stent Stories
A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical trial.
A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach.
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention (PCI).
As the US population ages and obesity rises, cardiovascular device markets reach billions in market value. Vancouver, BC (PRWEB) October 29, 2013 iData
Reportbuyer.com just published a new market research report:
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
More Images (2 images) »